Arkadios Wealth Advisors Grows Stock Position in Veeva Systems Inc. $VEEV

Arkadios Wealth Advisors increased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 9.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,632 shares of the technology company’s stock after buying an additional 327 shares during the quarter. Arkadios Wealth Advisors’ holdings in Veeva Systems were worth $1,046,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in VEEV. Mirae Asset Global Investments Co. Ltd. lifted its position in Veeva Systems by 394.9% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,222 shares of the technology company’s stock worth $755,000 after buying an additional 2,571 shares during the period. Amalgamated Bank grew its holdings in shares of Veeva Systems by 5.0% during the 1st quarter. Amalgamated Bank now owns 10,949 shares of the technology company’s stock worth $2,536,000 after purchasing an additional 520 shares during the period. Mather Group LLC. increased its position in Veeva Systems by 144.3% during the 1st quarter. Mather Group LLC. now owns 259 shares of the technology company’s stock worth $60,000 after purchasing an additional 153 shares in the last quarter. Private Trust Co. NA raised its holdings in Veeva Systems by 35.0% in the first quarter. Private Trust Co. NA now owns 247 shares of the technology company’s stock valued at $57,000 after buying an additional 64 shares during the period. Finally, First Horizon Advisors Inc. lifted its position in Veeva Systems by 27.4% during the first quarter. First Horizon Advisors Inc. now owns 526 shares of the technology company’s stock valued at $122,000 after buying an additional 113 shares in the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $291.20 on Friday. The business has a 50-day moving average of $285.22 and a 200-day moving average of $272.54. The company has a market capitalization of $47.73 billion, a PE ratio of 59.80, a P/E/G ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 1-year low of $201.54 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The business had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. During the same quarter in the prior year, the business earned $1.62 earnings per share. The firm’s revenue was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, equities analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on VEEV shares. Canaccord Genuity Group increased their price objective on shares of Veeva Systems from $270.00 to $300.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Oppenheimer reiterated an “outperform” rating and issued a $325.00 price target on shares of Veeva Systems in a report on Thursday, August 28th. Weiss Ratings reissued a “hold (c+)” rating on shares of Veeva Systems in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised Veeva Systems from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $290.00 to $330.00 in a research report on Monday, September 8th. Finally, Truist Financial raised their target price on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a report on Thursday, August 28th. Seventeen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and an average target price of $307.58.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 3,350 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the completion of the sale, the insider owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the sale, the insider owned 25,325 shares of the company’s stock, valued at approximately $7,765,151.50. This trade represents a 19.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. 10.30% of the stock is owned by corporate insiders.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.